Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Doshi

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Heart Rhythm|January 22, 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trialAdi Lador, Leif E Peterson, Vijay Swarup, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 16, 2023
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registryNoman Ali, David Hildick-Smith, Jessica Parker, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
Interventional Cardiology (London, England)|February 12, 2026
Transcatheter Aortic Valve Implantation: British Cardiovascular Intervention Society Position StatementDavid Hildick-Smith, Daniel J Blackman, Jonathan Byrne, et al.
Heart (British Cardiac Society)|July 22, 2018
Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantationRodrigo Bagur, Glen Philip Martin, Luis Nombela-Franco, et al.
JACC. Clinical Electrophysiology|November 7, 2025
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation: OPTION Trial Sub-analysisArwa Younis, Devi G Nair, Luigi Di Biase, et al.
JACC. Cardiovascular Interventions|September 24, 2021
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical TrialTiffany Patterson, Tim Clayton, Matthew Dodd, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Journal of the American College of Cardiology|February 9, 2019
Long-Term Durability of Transcatheter Aortic Valve ProsthesesDaniel J Blackman, Smriti Saraf, Philip A MacCarthy, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Heart Rhythm|January 22, 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trialAdi Lador, Leif E Peterson, Vijay Swarup, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 16, 2023
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registryNoman Ali, David Hildick-Smith, Jessica Parker, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
Interventional Cardiology (London, England)|February 12, 2026
Transcatheter Aortic Valve Implantation: British Cardiovascular Intervention Society Position StatementDavid Hildick-Smith, Daniel J Blackman, Jonathan Byrne, et al.
Heart (British Cardiac Society)|July 22, 2018
Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantationRodrigo Bagur, Glen Philip Martin, Luis Nombela-Franco, et al.
JACC. Clinical Electrophysiology|November 7, 2025
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation: OPTION Trial Sub-analysisArwa Younis, Devi G Nair, Luigi Di Biase, et al.
JACC. Cardiovascular Interventions|September 24, 2021
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical TrialTiffany Patterson, Tim Clayton, Matthew Dodd, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Journal of the American College of Cardiology|February 9, 2019
Long-Term Durability of Transcatheter Aortic Valve ProsthesesDaniel J Blackman, Smriti Saraf, Philip A MacCarthy, et al.
Pageof 24